Board
Screen
Heat
Cal
Watch
News
Blog
TV
News

MUEL Stock Declines 1.5% Despite Strong Y/Y Earnings Growth in Q3

Paul Mueller (MUEL) shares fell 1.5% despite the company reporting strong year-over-year earnings growth in Q3, driven by industrial equipment demand and improved margins.…
Yesterday, 1:56 PM ·

Zoetis plans cautiously for 2027 as pet owners cut back on vet visits, shares fall

Zoetis (ZTS) shares rose after the company beat third-quarter earnings and revenue estimates and improved its 2026 profit outlook, though organic operational revenue fell 1% in the…
Yesterday, 1:55 PM ·

Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch

Democrats winning both the House and Senate in the Nov. 3, 2026 midterms has put Medicare for All back on Wall Street's radar, per MarketBeat. The article flags three healthcare…
Yesterday, 1:55 PM ·

Novavax, Inc. (NVAX) Q3 2026 Earnings Call Transcript

Novavax (NVAX) held its Q3 2026 earnings call on Nov. 5, 2026, with the transcript published via Seeking Alpha. According to MarketBeat's coverage of the call, Novavax raised its…
Yesterday, 1:54 PM ·

Seaport Entertainment Group Inc. (SEG) Q3 2026 Earnings Call Transcript

Seaport Entertainment Group (SEG) held its Q3 2026 earnings call on Nov. 5, 2026, according to a transcript published by Seeking Alpha. The article provides no financial figures…
Yesterday, 1:54 PM ·

Sphere Entertainment Co. (SPHR) Q3 2026 Earnings Call Transcript

Sphere Entertainment Co. (SPHR) held its Q3 2026 earnings call, with the transcript published Nov. 5, 2026. The article provides no financial figures, segment results or forward…
Yesterday, 1:54 PM ·

Nutrien Ltd. (NTR:CA) Q3 2026 Earnings Call Transcript

Nutrien Ltd. (NTR:CA) held its Q3 2026 earnings call on November 5, 2026, with CEO Kenneth Seitz and CFO Mark Thompson leading the discussion. The transcript lists participation…
Yesterday, 1:54 PM ·

ALL Q3 Earnings Beat on Protection Services Unit Strength

Allstate (ALL) reported Q3 earnings that beat estimates by 38.8%, driven by growth in its Protection Services unit and higher investment income. Results held up despite surging…
Yesterday, 1:51 PM ·

Dycom M&A Strategy Accelerates: Can It Expand Beyond Core Fiber?

Dycom Industries (DY) is accelerating acquisition-driven expansion beyond traditional fiber infrastructure into data center electrical systems, structured cabling and…
Yesterday, 1:51 PM ·

KE Hodlings (BEKE) Surges 5.5%: Is This an Indication of Further Gains?

KE Holdings (BEKE) rose 5.5% in the prior session on above-average trading volume. The move came despite recent earnings estimate revisions that may not support further near-term…
Yesterday, 1:51 PM ·
Novavax, Inc. (NVAX) Q3 2026 Earnings Call Transcript
Yesterday, 1:54 PM·
Medium Optimistic

Sources

Summarized by i88

Tickers

Summary

Novavax (NVAX) held its Q3 2026 earnings call on Nov. 5, 2026, with the transcript published via Seeking Alpha. According to MarketBeat’s coverage of the call, Novavax raised its 2026 revenue framework after partner Sanofi began a late-stage trial in Europe of a combination influenza and COVID-19 vaccine, triggering a $125 million milestone payment to Novavax.

Novavax (NASDAQ: NVAX) raised its 2026 revenue framework, according to MarketBeat’s coverage of the company’s Q3 earnings call.

Sanofi Milestone Drives Revision

The revision followed partner Sanofi’s start of a late-stage trial in Europe of a combination influenza and COVID-19 vaccine.

  • The trial’s start triggered a $125 million milestone payment to Novavax.
  • Novavax is described as a vaccine technology company.

Call Details

The Q3 2026 earnings call was held on Nov. 5, 2026, with the transcript published via Seeking Alpha. MarketBeat published its coverage of the call on Nov. 6, 2026.